Riskpilot← Back to searchSign inGet full accessPharmagen ApS
APSActiveCVR 36687193Grusbakken 2DManufacture of pharmaceutical preparations · NACE 2120Est. 2015— employees
Revenue 2025
DKK -16K
+12% vs 2024
EBITDA margin
100.0%
-12% vs 2024
Equity ratio
-28.3%
Financial strength
Net profit 2025
DKK 36K
+287% vs 2024
| Revenue | DKK -16K | +12% |
| EBITDA | DKK -16K | -12% |
| Net profit | DKK 36K | +287% |
| Total assets | DKK 973K | +4% |
| Equity | DKK -275K | +12% |
| Employees | — | — |
Legal name
Pharmagen ApS
CVR number
36687193
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
18. marts 2015
Share capital
DKK 50.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af 1 direktør alene.
Company purpose
Virksomhedens formål er at udvikle og formidle lægemidler til videresalg.
Address
Grusbakken 2D
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 397 | 357 | 345 | 382 | 373 | 337 | 8 | -10 | -14 | -16 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 6 | 397 | 357 | 345 | 382 | 373 | 337 | 8 | -10 | -14 | -16 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 6 | 397 | 357 | 345 | 382 | 373 | 337 | 8 | -10 | -14 | -16 |
| Net financials | -2 | -17 | -11 | -506 | -1.544 | -275 | 119 | -6 | 25 | -5 | 52 |
| Profit before tax | 4 | 379 | 346 | -161 | -1.162 | 98 | 457 | 1 | 15 | -19 | 36 |
| Tax | 1 | 84 | 76 | 75 | -255 | 22 | 73 | 244 | -0 | -0 | -0 |
| Net profit | 3 | 296 | 270 | -237 | -907 | 76 | 383 | -242 | 15 | -19 | 36 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 429 | 1.267 | 1.720 | 1.480 | 615 | 884 | 1.227 | 966 | 952 | 933 | 973 |
| Equity | 53 | 349 | 619 | 383 | -524 | -448 | -65 | -307 | -292 | -311 | -275 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 376 | 918 | 1.101 | 1.097 | 1.140 | 1.332 | 1.292 | 1.273 | 1.244 | 1.244 | 1.248 |
| Total debt | 376 | 918 | 1.101 | 1.097 | 1.140 | 1.332 | 1.292 | 1.273 | 1.244 | 1.244 | 1.248 |
EBITDA margin
-1593300.0%
This company
15.8%
Market median
-10084277% vs market
20152025
Equity ratio
-28.3%
This company
38.2%
Market median
-174% vs market
20152025
Return on equity
3602300.0%
This company
18.4%
Market median
+19577617% vs market
20152025
Net profit margin
3602300.0%
This company
8.1%
Market median
+44472740% vs market
20152025
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20152025
Debt / equity
4.54×
This company
0.62×
Market median
-632% vs market
20152025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2015-03-18 – 2015-09-30
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharmagen ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|